WHO ICTRP trial

A Randomised control trial comparing the efficacy of two drugs namely Carbetocin…

CTRI/2022/09/045254 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2022/09/045254
Public title A Randomised control trial comparing the efficacy of two drugs namely Carbetocin and Oxytocin in the active management of third stage of labour
Scientific title Efficacy Of Carbetocin Against Oxytocin In Active Management Of Third Stage Of Labour In Vaginal Deliveries ââ?¬â??A Randomised Controlled Trial
Primary sponsor RAJAGIRI HOSPITAL
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Interventions Intervention1: Carbetocin: 100 mcg intravenously over 1 minute without dilution Control Intervention1: Oxytocin: Oxytocin 5 units in 5 ml normal saline intravenously,10 units of Oxytocin intramuscularly and 20 units of Oxytocin in 500 ml…
Registration date Jun 9, 2022
Target size 588
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations